Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radium-223 in Renal Cell Carcinoma with Bone Metastases
NCT02880943Phase 2Unknown
- Sponsor
- ARTIC
- Start
- Oct 2016
- Primary completion
- Oct 2020
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of radium-223 dichloride in renal cell carcinoma (RCC), sponsored by ARTIC. Status: unknown.
02
Drugs
radium-223 dichloride
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT02880943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880943.